妊娠及产后人群COVID-19疫苗接种犹豫的特征及相关认知:一项横断面研究
该横断面研究在单一学术三级医疗中心产前保健人群中开展,2021年3月22日至4月2日共纳入456人(95%为孕妇),COVID-19疫苗犹豫发生率为46%(95%CI 41%-51%)。非西班牙裔黑人、年轻、低教育、公共医保、产次>1及物质使用与更高疫苗犹豫几率相关,而亲友接种过疫苗、既往或计划接种Tdap和/或流感疫苗、认为疫苗对婴儿有益者更不易犹豫。
要点
- 妊娠及产后人群COVID-19疫苗犹豫发生率为46%(95%CI 41%-51%)。
- 非西班牙裔黑人、年轻、低教育、公共医保、产次>1及物质使用与更高犹豫几率相关。
- 亲友接种过疫苗、既往或计划接种Tdap和/或流感疫苗、认为疫苗对婴儿有益者更不易犹豫。
核心结论
- 妊娠及产后人群中COVID-19疫苗犹豫常见。
- 可能面临医疗保健服务获取障碍者更可能报告疫苗犹豫。
- 这些结果可为增加妊娠期COVID-19疫苗接种的干预措施提供信息。
研究设计与样本
- 横断面研究,在单一学术三级医疗中心产前保健中开展。
- 2021年3月22日至2021年4月2日筛查并接触485人,456人(94%)入组并完成调查(435/456,95%为孕妇)。
- 采用逻辑回归识别与COVID-19疫苗犹豫相关的特征,并调整年龄、产次、种族、妊娠期别和慢性合并症。
主要发现
- COVID-19疫苗犹豫发生率为46%(95%CI 41%-51%)。
- 非西班牙裔黑人种族、较年轻年龄、较低教育程度、公共健康保险、产次>1及报告物质使用与COVID-19疫苗犹豫更高几率相关,但临床风险状况不相关。
- 有家人或朋友接种过COVID-19疫苗、既往或计划接种破伤风-白喉-无细胞百日咳(Tdap)和/或流感疫苗、认为接种疫苗对婴儿有益者更不可能表达COVID-19疫苗犹豫。
关键数值与推荐
- COVID-19疫苗犹豫定义为:尽管疫苗服务可及,仍对疫苗不确定或拒绝,依据世界卫生组织(WHO)疫苗犹豫战略咨询专家组(SAGE)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the frequency and associated characteristics of COVID-19 vaccine hesitancy among pregnant and postpartum individuals. DESIGN: Cross-sectional study. SETTING: Prenatal care at a single academic tertiary care centre. POPULATION: Pregnant and postpartum individuals enrolled in prenatal care at a single academic tertiary care centre from 22 March 2021 to 2 April 2021, concurrent with state guidelines recommending COVID-19 vaccination in pregnancy. METHODS: We used logistic regression to identify characteristics associated with COVID-19 vaccine hesitancy, and adjusted for: age, parity, race, trimester of pregnancy, and chronic comorbidities. MAIN OUTCOME MEASURES: COVID-19 vaccine hesitancy, defined as uncertainty or refusal of the vaccine, despite the availability of vaccine services, in accordance with the World Health Organization (WHO) Strategic Advisory Group of Experts (SAGE) on vaccine hesitancy. RESULTS: Of the 485 individuals screened and approached, 456 (94%) enrolled and completed the survey (435/456, 95% pregnant). The frequency of COVID-19 vaccine hesitancy was 46% (95% CI 41%-51%). Sociodemographic characteristics, including non-Hispanic Black race, younger age, lower education, public health insurance receipt, parity >1, and reported substance use, were associated with a higher odds of COVID-19 vaccine hesitancy, but not clinical risk conditions. Individuals who had a family or friend vaccinated for COVID-19, prior or planned vaccination for tetanus, diphtheria and acellular pertussis (Tdap) and/or influenza, and who perceived that vaccination benefited the baby were less likely to express COVID-19 vaccine hesitancy. CONCLUSIONS: COVID-19 vaccine hesitancy was frequent among pregnant and postpartum individuals. Those who may face barriers to accessing healthcare services were more likely to report vaccine hesitancy. These results can inform interventions to increase COVID-19 vaccine uptake in pregnancy. TWEETABLE ABSTRACT: COVID-19 vaccination hesitancy is frequent among pregnant and postpartum individuals, and those who face barriers to accessing healthcare services are more likely to report COVID-19 vaccine hesitancy.
引用
- Kiefer MK, Mehl R, Costantine MM, et al. Characteristics and perceptions associated with COVID-19 vaccination hesitancy among pregnant and postpartum individuals: A cross-sectional study. BJOG. 2022. PMID: 35104382. doi:10.1111/1471-0528.17110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。